IMatinib IMidazole IMpurity, identified by the CAS number 1256080-10-0, is a chemical substance that is typically associated with the pharmaceutical compound imatinib, which is a tyrosine kinase inhibitor used primarily in the treatment of certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). The term "imidazole" suggests the presence of an imidazole ring, a five-membered heterocyclic compound containing two nitrogen atoms, which may play a role in the compound's biological activity or stability. Impurities in pharmaceutical compounds can arise during synthesis or storage and may affect the efficacy and safety of the drug. Characterization of such impurities is crucial for quality control in pharmaceutical manufacturing. The specific properties, such as solubility, stability, and reactivity, would depend on the molecular structure and the presence of functional groups. Understanding these characteristics is essential for ensuring the compound's safety and effectiveness in therapeutic applications.

IMatinib IMidazole IMpurity

1256080-10-0: IMatinib IMidazole IMpurity, identified by the CAS number 1256080-10-0, is a chemical substance that is typically associated with the pharmaceutical compound imatinib, which is a tyrosine kinase inhibitor used primarily in the treatment of certain cancers, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). The term "imidazole" suggests the presence of an imidazole ring, a five-membered heterocyclic compound containing two nitrogen atoms, which may play a role in the compound's biological activity or stability. Impurities in pharmaceutical compounds can arise during synthesis or storage and may affect the efficacy and safety of the drug. Characterization of such impurities is crucial for quality control in pharmaceutical manufacturing. The specific properties, such as solubility, stability, and reactivity, would depend on the molecular structure and the presence of functional groups. Understanding these characteristics is essential for ensuring the compound's safety and effectiveness in therapeutic applications.

CAS 1256080-10-0

IMatinib IMidazole IMpurity

Imatinib Imidazole Impurity

Ref: ST-EA-CP-I5041